Prosecution Insights
Last updated: October 04, 2026

UNIVERSITE DE PARIS

Technology area: Biotechnology & Pharmaceuticals

2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

UNIVERSITE DE PARIS currently has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 2 pending office actions are being reviewed by 2 distinct examiners, which suggests that each active application is receiving a unique perspective from the USPTO. Despite the involvement of multiple examiners, the entire pending portfolio is situated within 1 distinct art unit, providing a centralized technical environment for these life sciences matters.

The busiest examiner for the university is GIAMMONA, FRANCESCA FILIPPA, who is responsible for 1 busiest examiner pending office action. With 2 distinct examiners involved in the 2 pending office actions, the workload is distributed, meaning no single examiner dominates the current prosecution landscape. This distribution requires the applicant to adapt to the specific nuances of GIAMMONA, FRANCESCA FILIPPA while simultaneously managing a separate set of requirements from the other examiner.

The concentration of all activity in 1 distinct art unit is a significant factor for the Biotechnology & Pharmaceuticals filings. It implies that the technical subject matter is closely related, even if the 2 distinct examiners bring different levels of scrutiny to the applications. Practitioners should focus on the specific tendencies of GIAMMONA, FRANCESCA FILIPPA to resolve the 1 busiest examiner pending office action, while monitoring the single art unit for broader trends in pharmaceutical examination.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
0
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (50%)
1
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other1 (50%)
Multi-statute (no §101)1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GIAMMONA, FRANCESCA FILIPPA 1 37.5% +57.4%
YU, TIAN NMN 1 55.1% +20.4%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17614023 METHOD OF DIGITAL MULTIPLEX DETECTION AND/OR QUANTIFICATION OF BIOMOLECULES AND USE THEREOF GIAMMONA, FRANCESCA FILIPPA 30d overdue

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17614023 METHOD OF DIGITAL MULTIPLEX DETECTION AND/OR QUANTIFICATION OF BIOMOLECULES AND USE THEREOF GIAMMONA, FRANCESCA FILIPPA 30d overdue
17613990 DIGITAL BIOMOLECULES DETECTION AND/OR QUANTIFICATION USING ISOTHERMAL AMPLIFICATION YU, TIAN NMN —

Top Art Units

Art UnitApps
1681 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17614023 METHOD OF DIGITAL MULTIPLEX DETECTION AND/OR QUANTIFICATION OF BIOMOLECULES AND USE THEREOF GIAMMONA, FRANCESCA FILIPPA 1681 §103§112 Final Rejection 30d overdue Pending Nov 24, 2021
17613990 DIGITAL BIOMOLECULES DETECTION AND/OR QUANTIFICATION USING ISOTHERMAL AMPLIFICATION YU, TIAN NMN 1681 §103§112DP Final Rejection — Pending Nov 24, 2021

Managing UNIVERSITE DE PARIS's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month